Uncategorized
Double Certification: ISO 9001 and Cyber Essentials
ImmunoServ is delighted to announce that the company’s commitment to Quality Assurance and Cyber Security has been independently verified.
Read MoreOmicron T cell test under development
Following the WHOs announcement about the new SARS-CoV-2 Omicron variant of concern (VoC) on 26 November 2021, the team here at ImmunoServ have started working on a T cell immune response test for this variant. This rapid development demonstrates the flexibility of our T cell testing platform and the dedication of our company to help in the ongoing fight against COVID-19.
Read MoreSingle blood test to measure T-cell and antibody response to SARS-CoV-2
ImmunoServ have been featured by Cardiff University for our work on a test to measure both the T-cell and antibody response to SARS-CoV-2 in a single blood sample.
Read MoreIncorporation
We are delighted to announce the incorporation of ImmunoServ Ltd., a specialist contract research organisation in the immunology sector.
Read More